| New Data From EMBLEM(TM) Study Show Pipeline Drug Epratuzumab Provided ... - MarketWatch (press release) |
|
|
MarketWatch (press release)These systems were: musculoskeletal, mucocutaneous, cardiorespiratory, neuropsychiatric, constitutional and renal. "Achieving a BILAG improvement without ... read more |